Status:
UNKNOWN
Registration Study of Amyotrophic Lateral Sclerosis (ALS) in Mainland China
Lead Sponsor:
Peking University Third Hospital
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18-80 years
Brief Summary
A multi-center registration study of natural history and clinical characteristics of ALS in mainland China
Detailed Description
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease of unknown etiology that is currently incurable. This study is a national multi-center registration study. The st...
Eligibility Criteria
Inclusion
- Clinical diagnosis of laboratory-supported probable, probable, or definite ALS according to EI Escorial diagnostic criteria
- Age: 18-70 years
Exclusion
- Refuse to cooperate or reject the informed consent
Key Trial Info
Start Date :
March 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 20 2023
Estimated Enrollment :
4752 Patients enrolled
Trial Details
Trial ID
NCT04328675
Start Date
March 20 2020
End Date
March 20 2023
Last Update
April 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191